title: Predicting the clinical course of prostate cancer.
abstract: Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients.
authors.affiliation: Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
authors.forename: James
authors.initials: J
authors.lastname: McKiernan
authors.forename: Mitchell C
authors.initials: MC
authors.lastname: Benson
mesh_terms: D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000503:physiopathology*